Merck KGaA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRKC.SG | KRK.WA | 002720.KS | 4521.T | 3933.HK | MERK.JK | |
|---|---|---|---|---|---|---|
| Market cap | 65.22B | 33.24B | 70.36B | 147.31B | 15.37B | 1.58T |
| P/E (TTM) | 27.5 | 18.8 | — | 69.0 | 28.9 | 4.8 |
| Forward P/E | — | — | — | 40.4 | 11.3 | — |
| Price/book | 2.2 | 12.7 | — | 1.0 | 0.8 | 1.7 |
| Dividend yield | 1.47% | 3.61% | 0.89% | 5.03% | 6.47% | 8.02% |
| 1-year change | +36.11% | +22.70% | −20.94% | +3.00% | −41.08% | +10.65% |
| Today | +2.04% | +0.55% | −1.63% | +2.91% | +6.41% | +2.92% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All MRKC.SG news ›Lonza to acquire five US manufacturing sites from Merck KGaA
The deal would expand Lonza’s US presence from four to nine sites and bring 1,100 employees into its global workforce. Lonza has entered a definitive agreement to purchase five US contract development and manufacturing organisation (CDMO)…
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt…
Lonza to Acquire Merck KGaA’s US CDMO Business, Adding ADC, Viral Vector, and LNP Capacity
The deal adds five US sites and about 1,100 employees, more than doubling Lonza’s US network and filling a gap in US bioconjugation capacity the company flagged weeks earlier. “It will significantly expand our US presence, bringing us even…
Merck KGaA to divest CDMO business to Lonza
November 3, 2026 | By Mary Bailey Lonza will acquire the business for a mid-triple-digit million-euro amount. The transaction is expected to close in mid-2027, subject to customary regulatory approvals and other closing conditions. The…
Lonza to buy Merck KGaA’s contract manufacturing business
The Swiss contract development and manufacturing organization (CDMO) Lonza has agreed to buy the drug services business of Germany’s Merck KGaA. The purchase will give Lonza five new manufacturing sites in the US, doubling the company’s US…
Portfolio reshuffle: Lonza buys Merck KGaA's CDMO arm
The sale gives Lonza added US manufacturing capacity and extends its run of portfolio reshaping, while Merck KGaA sharpens its life science focus. Germany’s Merck has signed an agreement to sell its contract development and manufacturing…
Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion
Lonza has struck a deal to buy five U.S. manufacturing plants from Merck KGaA at a valuation ranging in the low- to mid-triple-digit millions in Swiss francs. Responding to an analyst on a conference call Tuesday, Lonza CEO Wolfgang…
Lonza to Buy Merck KGaA's US CDMO Sites, Lifting American Footprint to Nine Plants
Lonza Group AG has agreed to acquire the contract development and manufacturing organization (CDMO) business of Germany's Merck KGaA, a deal that will take the Swiss contractor's U.S. production network from four sites to nine and add…
Top Players Merck KGaA, Danaher, and Sartorius in the Next-Generation Biomanufacturing Market as It Reaches USD 44.37 Billion by 2035
Top Players Merck KGaA, Danaher, and Sartorius in openPR.com Top Players Merck KGaA, Danaher, and Sartorius in the Next-Generation Biomanufacturing Market as It Reaches USD 44.37 Billion by 2035 Press release from: Future Market Insights…
Merck KGaA : Deutsche Bank reaffirms its Neutral rating
Published on 10/28/2026 at 06:06 am EDT Merck: Operational resilience over the years, cannot be overlooked September 04, 2026 at 08:34 am EDT Merck KGaA: From 19th-century cocaine to tomorrow's AI chips Merck CEO on US Business, Life…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com18
- openpr.com7
- biospace.com2
- finance.biggo.com2
- pharmaceutical-technology.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 58 articles, not a forecast.